The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Share News (OVB)

Share Price Information for Ovoca Bio (OVB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.825
Bid: 0.75
Ask: 0.90
Change: 0.00 (0.00%)
Spread: 0.15 (20.00%)
Open: 0.825
High: 0.825
Low: 0.825
Prev. Close: 0.825
OVB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS SUMMARY: Powerhouse loss widens hugely, DCI Advisors narrows

Fri, 30th Jun 2023 17:26

(Alliance News) - The following is a round-up of 2022 annual results by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Ovoca Bio PLC - Dublin-based biopharmaceutical company with a focus on women's health - Pretax loss for 2022 is EUR5.6 million, ticking up from USD5.2 million in 2021. Reports no revenue, unchanged. Administrative expenses fall to EUR5.4 million from EUR6.1 million. Other loss is EUR154,000, swinging from a gain of EUR766,000. Chief Executive Officer Kirill Golovanov says: "During 2022, we continued to progress our ongoing phase 2 dose ranging study being undertaken in Australia and New Zealand. The recruitment of participants into the study finished in July 2022, with all required study data collection activities then completed in December. The study results are currently expected to be delivered in August 2023...I continue to believe Ovoca is well positioned to achieve our vision of becoming a leader in the research and development of, and commercial partner of choice for, novel medicines in areas of high unmet need that affect women."

----------

Alien Metals Ltd - mineral exploration and development company with assets in Australia, Mexico and Greenland - Pretax loss in 2022 is AUD2.4 million, or GBP1.3 million, widening from AUD2.3 million in 2021. Reports no revenue, unchanged. Administrative expenses tick up to AUD2.4 million from AUD2.3 million, alongside one-off losses of AUD30,000 in 2022. Executive Chair Guy Robertson says: "During the year, we made significant progress in our exploration and development projects in Australia. Our flagship project, the Hancock iron ore project in Western Australia, has continued to demonstrate strong potential for high-grade direct ship iron ore, and we remain well-positioned to capitalise on the growing demand for iron ore in China...Looking ahead, we remain focused on delivering long-term value for our shareholders by continuing to advance our exploration and development projects. The acquisitions we have made during the year strengthen our portfolio and provide us with additional growth opportunities." Also notes Rod McIlree resigns as executive director, effective Friday.

----------

DCI Advisors Ltd - London-based real estate investment trust - Pretax loss in 2022 narrows to EUR5.8 million from EUR21.2 million. This is largely driven from change valuations narrowing to negative EUR3.0 million from negative EUR24.6 million. Revenue plummets to EUR318,000 from EUR4.7 million, while costs of sales is nothing from EUR2.8 million. Says its main objectives for 2023 are to execute further portfolio asset disposals, progress construction at its main asset Kilada Country Club, Golf & Residences and generate plot and villa sales momentum at the project, secure adequate working capital liquidity for DCI and to defend its claim against DCP and pursue all legal options to recover the value arising from the undisclosed option agreement. This relates to terminating Dolphin Capital Partners Ltd as its investment manager in March.

----------

Powerhouse Energy Group PLC - Bingley, England-based hydrogen-from-waste-plastic producer - Pretax loss in 2022 widens to GBP46.2 million from GBP1.8 million. This is due to exceptional items, such as a one-off goodwill impairment of GBP40.7 million in 2022. This is alongside a one-off loan impairment of GBP2.2 million, one-off revenue impairment of GBP986,392 and one-off exclusivity impairment of GBP500,000. Revenue also almost halves to GBP380,277 from GBP701,435. Acting Chief Executive Officer Keith Riley says: "The year under review was a challenging one for Powerhouse, but one that I believe will be ultimately rewarding. It was the year that started a change that the board believe will move the company towards its goal of trading profitably and being at the forefront of the waste-to-energy sector."

----------

Amur Minerals Corp - Russia-focused nickel copper sulphide exploration company - Pretax loss is GBP2.6 million in 2022, widening from GBP1.8 million in 2021. This is almost entirely due to administrative and other expenses widening to GBP2.6 million from GBP1.8 million. Says it continues to explore viable options for a reverse takeover.

----------

By Greg Rosenvinge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
6 Oct 2022 17:17

TRADING UPDATES: Nostra revenue rises; Synergia eyes Cambay farm-out

(Alliance News) - The following is a round-up of updates by London-listed companies, issued last week and not separately reported by Alliance News:

Read more
29 Jul 2022 19:36

TRADING UPDATES: Walker Crips assets grow; Minoan interim loss narrows

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
29 Jul 2022 16:00

Ovoca Bio enrols participants in women's sexual drug trial

(Sharecast News) - Women's health-focussed biopharmaceutical company Ovoca Bio announced the successful completion of participant enrollment in a phase 2 dose-ranging study assessing 'orenetide' on Friday.

Read more
30 Jun 2022 12:17

EARNINGS UPDATES: Live Co revenue rises; Ovoca cautions on Russia

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Feb 2022 21:57

TRADING UPDATES: Angling Direct ups revenue; Ceiba takes Omicron hit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
5 Nov 2021 13:39

EXECUTIVE CHANGES: MP Evans promotes Finance Director Coulson as CEO

EXECUTIVE CHANGES: MP Evans promotes Finance Director Coulson as CEO

Read more
14 Sep 2021 17:46

TRADING UPDATES: Strong annual results from Springfield, Fiske

TRADING UPDATES: Strong annual results from Springfield, Fiske

Read more
22 Jul 2021 16:04

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
9 Feb 2021 16:16

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
29 Jan 2021 18:26

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

Read more
29 Jan 2021 11:15

Ovoca Bio enrols first patient in sexual desire treatment trial

(Sharecast News) - Biopharmaceutical company Ovoca Bio said on Friday that the first patient has been enrolled in a phase 2 dose-ranging study assessing 'BP-101', which it described as a novel treatment for premenopausal women with hypoactive sexual desire disorder (HSDD) - a condition characterised by a distressing lack or loss of sexual desire.

Read more
5 Jan 2021 19:02

IN BRIEF: Ovoca Refiles Marketing Application With Russian Regulator

IN BRIEF: Ovoca Refiles Marketing Application With Russian Regulator

Read more
10 Dec 2020 15:54

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
9 Oct 2020 17:24

IN BRIEF: Ovoca Bio Names Wiltshire As Chief Business Officer

IN BRIEF: Ovoca Bio Names Wiltshire As Chief Business Officer

Read more
9 Oct 2020 15:47

Ovoca Bio appoints new chief business officer

(Sharecast News) - Women's health-focussed biopharmaceuticals company Ovoca Bio announced the appointment of Christopher Wiltshire as its chief business officer and executive director of the board on Friday, effective immediately.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.